Science Explorer Back to mapMap

Metabolism, Diabetes, and Cancer

Metabolism, Diabetes, and Cancer is a research topic within Molecular Biology. Science Explorer counts 45k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.

  • AMP-activated Protein Kinase
  • Metformin
  • Glucose
  • Insulin Signaling
  • Cancer Risk
  • Cellular Energy
  • Mitochondrial Homeostasis
  • Glycogen Metabolism
  • Regulation of Gene Expression
  • Tumor Suppression
Research works
45k
fractional, since 1950
In the world top 10%
4.4k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-1%
the tick is no change
Largest producer
China
32% of the 10 largest, 2022-now

Which countries lead Metabolism, Diabetes, and Cancer research?

By volume, China and the United States publish the most (1.5k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.5k works
  2. 2 United States 1.4k works
  3. 3 India 407 works
  4. 4 Japan 281 works
  5. 5 South Korea 247 works
  6. 6 Italy 235 works
  7. 7 United Kingdom 220 works
  8. 8 Germany 192 works
  9. 9 Canada 138 works
  10. 10 Iran 137 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 31.8%United States: 29.2%India: 8.5%Japan: 5.9%6 others listed: 24.6%32%largest
China1,510 · 31.8%United States1,391 · 29.2%India407 · 8.5%Japan281 · 5.9%6 others listed1,168 · 24.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Metabolism, Diabetes, and Cancer research?

By volume in 2022-now, Harvard University publishes the most Metabolism, Diabetes, and Cancer research, followed by Shanghai Jiao Tong University and Chinese Academy of Medical Sciences & Peking Union Medical College.

Who are the leading researchers in Metabolism, Diabetes, and Cancer?

The most-cited researchers publishing on Metabolism, Diabetes, and Cancer include David Moher, Eric S. Lander and Rob Knight.

  1. 1 David Moher Canada 898k citations
  2. 2 Eric S. Lander United States 524k citations
  3. 3 Rob Knight United States 468k citations
  4. 4 George Davey Smith United Kingdom 435k citations
  5. 5 Ali H. Mokdad United States 429k citations
  6. 6 Walter Churchill Willett United States 411k citations
  7. 7 Mark J. Daly United States 403k citations
  8. 8 Stacey L. Gabriel United States 402k citations
  9. 9 Julian P. T. Higgins United Kingdom 390k citations
  10. 10 Guido Kroemer France 386k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Metabolism, Diabetes, and Cancer?

The most cited paper in Metabolism, Diabetes, and Cancer is "Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man" (David Richard Matthews, J P Hosker, A. Rudenski et al., 1985), with 31,761 citations. Next come "Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin" (19,192) and "Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation" (16,511).

Most cited papers
#PaperReleasedCitations
1 Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David Richard Matthews, J P Hosker, A. Rudenski et al. · Diabetologia Open access Jul 1985 31,761
2 Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin Diabetes Prevention Program Research Group · New England Journal of Medicine Open access 7 Feb 2002 19,192
3 Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation Matthew G. Vander Heiden, Lewis C. Cantley, Craig B. Thompson · Science Open access 21 May 2009 16,511
4 Role of Insulin Resistance in Human Disease Gerald M. Reaven · Diabetes Dec 1988 12,183
5 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance Jaakko O. Tuomilehto, Jaana Lindström, Johan Gunnar Eriksson et al. · New England Journal of Medicine Open access 3 May 2001 10,985
All 100 most cited papers, with filters and sorting

Where is Metabolism, Diabetes, and Cancer research done?

The largest centres of Metabolism, Diabetes, and Cancer research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis and Düsseldorf.

Largest cities, 2022-now

  1. 1 BeijingChina 177 works
  2. 2 ShanghaiChina 118 works
  3. 3 SeoulSouth Korea 114 works
  4. 4 GuangzhouChina 86 works
  5. 5 TokyoJapan 70 works
  6. 6 NanjingChina 65 works
  7. 7 New YorkUnited States 64 works
  8. 8 HangzhouChina 55 works
  9. 9 MoscowRussia 55 works
  10. 10 LondonUnited Kingdom 55 works

Where it is the local speciality

  1. IndianapolisUS · 25.3 works6.0×
  2. DüsseldorfDE · 20.1 works5.7×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Metabolism, Diabetes, and Cancer than the world average.

See Metabolism, Diabetes, and Cancer on the map

Where is the best place to study Metabolism, Diabetes, and Cancer?

Among universities, judged by research, Harvard University, Case Western Reserve University and Sichuan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.17%fractional works in this field (log) →share of work in the world top 10% →Case Western Reserve…Sichuan UniversityHarvard UniversityChinese Academy of M…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 82.718.2%3.1×59 -8.6%
2Case Western Reserve UniversityUnited States 62.126.0%3.6×13 +102.3%
3Sichuan UniversityChina 61.722.3%2.1×28 +4.3%
4Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 60.616.3%4.8×30 +18.7%
5Peking UniversityChina 59.315.9%2.4×29 +39.8%
6Albert Einstein College of MedicineUnited States 58.319.3%5.0×10 +49.9%
7National and Kapodistrian University of AthensGreece 56.621.8%3.9×12 +21.2%
8Columbia UniversityUnited States 56.317.5%1.8×12 +19.9%
9McGill UniversityCanada 56.018.0%2.8×16 -13.4%
10University of OxfordUnited Kingdom 53.526.4%1.4×11 -25.2%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Metabolism, Diabetes, and Cancer, country by country

Is Metabolism, Diabetes, and Cancer research growing?

Output in 2022-2025 was 1% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Metabolism, Diabetes, and Cancer as a percentage of every work published that year, 0.028% in 2024.

still counting0.025%0.050%0.075%Metabolism, Diabetes, and Cancer0.027% in 202519801990200020102020

Fractional works of Metabolism, Diabetes, and Cancer over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Metabolism, Diabetes, and Cancer9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Metabolism, Diabetes, and Cancer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.